KROSHealthcare
Keros Therapeutics Inc (KROS) Insider Trading
In the last 90 days, 5 Keros Therapeutics Inc (KROS) insiders reported 1 open-market purchase totaling $10,270 and 4 sales totaling $101,136. The most recent open-market purchase was reported on Aug 17, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $10,270
- Corporate buyers
- 1
- Latest transaction
- Aug 18, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
KROS insider trading FAQ
- Are KROS insiders buying or selling?
- Over the last 90 days, KROS insiders were net sellers, reporting $10,270 of open-market purchases and $101,136 of sales.
- When was the last KROS insider purchase?
- The most recent open-market purchase of Keros Therapeutics Inc stock by an insider was reported on Aug 17, 2026, one of 1 purchase in the last 90 days.
- Where does KROS insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Keros Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- CSTL insider tradingCastle Biosciences Inc20 filings
- CLOV insider tradingClover Health Investments Corp18 filings
- MEDP insider tradingMedpace Holdings Inc18 filings
